AINewsBreaks - Monogram Technologies Inc. (NASDAQ: MGRM) Secures Indian Regulatory Approval for Robotic Knee Surgery Clinical Trial

Stock Information for Monogram Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Monogram Technologies Inc.

Monogram Technologies Reports First Quarter 2025 Financial Results
CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
Monogram Technologies Reports Full Year 2024 Financial Results
Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.